Microbiological diagnostic and antibiotic management of community aquired and nosocomial pneumonias in intensive care units in Germany: Data from project SARI - Surveillance of antibiotic use and bacterial resistance in intensive care units;Mikrobiologische diagnostik und antibiotika-management von ambulant und nosokomial erworbenen pneumonien auf intensivstationen in Deutschland: Daten aus dem projekt SARI - Surveillance der antibiotlka-anwendung und bakteriellen resistenzentwicklunq auf intensivstationen

Anasthesiologie Intensivmedizin Notfallmedizin Schmerztherapie

Volumn 40, Issue 2, 2005, Pages 85-90

  Meyer, E ^a   Ebner, W ^a   Heininger, A ^b   Schwab, F ^c   Ruden H ^c,d   Daschner, F D ^a,d  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d Natl Referenzzentrum Survlnc N I ^*

Author keywords

Empiric antibiotic treatment; Intensive care unit; Microbiological diagnostic; Pneumonia

Indexed keywords

BETA LACTAMASE INHIBITOR; CARBAPENEM; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLINDAMYCIN; ERYTHROMYCIN; FLUCLOXACILLIN; IMIPENEM; MACROLIDE; METRONIDAZOLE; OXACILLIN; PENICILLIN G; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLONE DERIVATIVE; SULTAMICILLIN; ANTIINFECTIVE AGENT; BETA LACTAMASE; ENZYME INHIBITOR; PENICILLIN DERIVATIVE;

ANTIBIOTIC RESISTANCE; ARTICLE; ASPIRATION PNEUMONIA; COMMUNITY ACQUIRED PNEUMONIA; DRUG SURVEILLANCE PROGRAM; GERMANY; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE; VENTILATOR ASSOCIATED PNEUMONIA; ARTIFICIAL VENTILATION; COMMUNICABLE DISEASE; CROSS INFECTION; DRUG ANTAGONISM; HEALTH SURVEY; INTENSIVE CARE UNIT; LUNG LAVAGE; MICROBIOLOGY; PNEUMONIA; PRACTICE GUIDELINE; QUESTIONNAIRE;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; BRONCHOALVEOLAR LAVAGE FLUID; CEPHALOSPORINS; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; ENZYME INHIBITORS; GERMANY; GUIDELINES; HUMANS; INTENSIVE CARE UNITS; PENICILLINS; PIPERACILLIN; PNEUMONIA; POPULATION SURVEILLANCE; QUESTIONNAIRES; RESPIRATION, ARTIFICIAL;

EID: 14744289356     PISSN: 09392661     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-825874     Document Type: Article

References (13)

1. Bergmans DC, Bonten MJ, Gaillard CA, van Tiel FH, van der Geest S, de Leeuw PW, Stobberingh EE. Indications for antibiotic use in ICU patients: a one-year prospective surveillance. J Antimicrob Chemother 1997; 39: 527-535
2. Fagon JY, Chastre J, Wolff M, Gervais C, Parer-Aubas S, Stephan F, Similowski T, Mercat A, Diehl JL, Sollet JP, Tenaillon A. Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia. A randomized trial. Ann Intern Med 2000; 132: 621-630
3. Kollef MH. Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. Clin Infect Dis 2000; 31: 131-138
4. Gruson D, Hubert G, Vargas F, Valentino R, Bui N, Pereyre S, Bebear C, Bebear CM, Gbikpi-Benissan G. Strategy of antibiotic rotation: long-term effect on incidence and susceptibilities of Gram-negative bacilli responsible for ventilator-associated pneumonia. Crit Care Med 2003; 31: 1908-1914
5. Lorenz J, Bodmann KF, Bauer TT, Ewig S, Trautmann M, Vogel F. Nosokomiale Pneumonie: Prevention, Diagnose und Therapie. Pneumologie 2003; 57: 532-545
6. Vogel F, Worth H, Adam D, Elies W, Ewig S, Höffken G, Lode H, Lorenz J, Scholz J, Stille W, Unertl K, Wiedemann B. Rationale Therapie bakterieller Atemwegsinfektionen. Empfehlungen einer Expertengruppe der Paul-Ehrlich- Gesellschaft für Chemotherapie e. V. und der Deutschen Atemwegsliga e. V. Chemotherapie Journal 2000; 9: 9-23
7. National Nosocomial Infections Surveillance (NNIS). System Report, data summary from January 1992 through June 2003, issued August 2003. Am J Infect Control 2003; 31: 481-498
8. Meyer E, Jonas D, Schwab F, Rueden H, Gastmeier P, Daschner FD. Design of a surveillance system of antibiotic use and bacterial resistance in German intensive Care units (SARI). Infection 2003; 31: 208-215
9. Ost DE, Hall CS, Joseph G, Ginocchio C, Condon S, Kao E, LaRusso M, Itzla R, Fein AM. Decision analysis of antibiotic and diagnostic strategies in ventilator-associated pneumonia. Am J Respir Crit Care Med 2003; 168: 1060-1067
10. Chastre J, Wolff M, Fagon JY, Chevret S, Thomas F, Wermert D, dementi E, Gonzalez J, Jusserand D, Asfar P, Perrin D, Fieux F, Aubas S. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA 2003; 290: 2588-2598
11. Geffers C, Zuschneid I, Sohr D, Ruden H, Gastmeier P. [Microbiological Isolates Associated with Nosocomial Infections in Intensive Care Units: Data of 274 Intensive Care Units Participating in the German Nosocomial Infections Surveillance System (KISS)]. Anasthesiol Intensivmed Notfallmed Schmerzther 2004; 39: 15-19
12. Harvey K, Dartnell J, Hemming M. Improving antibiotic use: 25 years of antibiotic guidelines and related initiatives. Commun Dis Intell 2003; 27 (Suppl): 9-12
13. Ramsay C, Brown E, Hartman G, Davey P. Room for improvement: a systematic review of the quality of evaluytions of interventions to improve hospital antibiotic prescribing. Journal of Antimicrobial Chemotherapy 2003; 52: 764-771